Establishment Labs shares are trading higher after the company announced FDA clearance of the Motiva Flora SmoothSilk Tissue Expander.
Portfolio Pulse from Benzinga Newsdesk
Establishment Labs has announced that the FDA has cleared its Motiva Flora SmoothSilk Tissue Expander, leading to a rise in the company's shares.
October 16, 2023 | 7:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Establishment Labs' shares are trading higher after the FDA clearance of its new product, the Motiva Flora SmoothSilk Tissue Expander.
The FDA clearance of Establishment Labs' new product, the Motiva Flora SmoothSilk Tissue Expander, is a positive development for the company. This approval can lead to increased sales and revenue, which is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100